24 x 7 World News

We are lowering our Bristol Myers price target despite an earnings beat

0

The logo of the pharmaceutical company Bristol-Myers Squibb, (BMS) is seen on the facade of the company’s Munich headquarters on August 29, 2024 in Munich (Bavaria). 

Matthias Balk | Picture Alliance | Getty Images

Bristol Myers Squibb‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now.

Leave a Reply